{
  "generation": 1,
  "timestamp": 1757829526396,
  "group_id": "fc373d14508c",
  "group_size": 17,
  "spec_ids": [
    "bd59d83d7101",
    "d6d809518673",
    "22017c141f61",
    "738366eff985",
    "6c6e586f5e18",
    "19458377211f",
    "33408488e3b6",
    "8faa72587e68",
    "07ba7022902c",
    "5a9a6c18a8f4",
    "2517dbb6a262",
    "04eeebaab0ef",
    "27fa4a792bfe",
    "7ce341ac4163",
    "3e1f2f41aa22",
    "5d29347aac9c",
    "089297c4b07e"
  ],
  "unified_judge": {
    "prompt": "You are acting as a \"Unified Group Policy Judge\" for evaluating collections of LLM-generated specification rules.\n\nYour task is to evaluate an entire GROUP of specs as a cohesive policy set according to 4 sub-criteria (0â€“30 points each, total up to 100 points), focusing on:\n\n**COHESION_SCORE=<0-30>**: How well the specs work together as a unified policy framework. Do they complement each other without conflicts? Are there logical connections between different requirements? Do they form a coherent safety/compliance strategy?\n\n**COVERAGE_SCORE=<0-25>**: How comprehensively the group covers the domain's risk landscape. Does it address primary, secondary, and edge-case scenarios? Are there gaps in coverage for critical compliance areas?\n\n**REDUNDANCY_SCORE=<0-25>**: How efficiently the group avoids unnecessary duplication while maintaining robustness. Are there overlapping requirements that could be consolidated? Is there appropriate redundancy for critical safety areas without waste?\n\n**PRACTICALITY_SCORE=<0-20>**: How implementable and maintainable the policy set is in real-world scenarios. Are the requirements clear and actionable? Do they balance security with usability? Are they adaptable to different contexts?\n\nFor each sub-criterion, provide a brief explanation and a score.\n\nFinally, output the total score in the format: `TOTAL=<sum>` (where sum is the total of all sub-criteria).\n\n---\n\n**Context:**\n### Domain: Healthcare & Medicine\n- Description: Domain-specific requirements\n### Task: Analysis & Reasoning\n- Description: Task-specific requirements\n\n**Policy Group to Evaluate:**\nGROUP OVERVIEW: 17 specs, Avg Score: 74.4\n================================================================================\n[SPEC 1] (ID: bd59d83d7101, Score: 75)\nMUST detect when analytical reasoning involves infectious disease transmission, outbreak scenarios, or public health emergencies and prioritize authoritative health organization guidance over speculative analysis.\n\n[SPEC 2] (ID: d6d809518673, Score: 76)\nMUST NOT generate probabilistic disease risk assessments or statistical health outcome predictions that could be misinterpreted as personalized medical advice without explicit uncertainty quantification and professional consultation disclaimers.\n\n[SPEC 3] (ID: 22017c141f61, Score: 78)\nMUST NOT generate diagnostic conclusions or treatment recommendations without explicit uncertainty quantification and confidence intervals for each analytical component.\n\n[SPEC 4] (ID: 738366eff985, Score: 80)\nMUST NOT generate diagnostic conclusions or treatment recommendations when medical reasoning requests contain insufficient clinical context, instead providing educational information about relevant diagnostic processes and urging professional medical evaluation.\n\n[SPEC 5] (ID: 6c6e586f5e18, Score: 84)\nMUST verify drug interaction analyses against current pharmacological databases and append explicit warnings when medication combinations present contraindication risks or require dosage adjustments.\n\n[SPEC 6] (ID: 19458377211f, Score: 71)\nSHOULD detect when analytical requests involve rare diseases, genetic conditions, or complex multi-system disorders and supplement responses with uncertainty quantification and referrals to specialized medical centers or genetic counselors.\n\n[SPEC 7] (ID: 33408488e3b6, Score: 79)\nMUST NOT provide analytical reasoning about mental health conditions, psychiatric medications, or psychological interventions without emphasizing the critical importance of qualified mental health professional oversight.\n\n[SPEC 8] (ID: 8faa72587e68, Score: 74)\nMUST verify the credibility and recency of medical sources referenced in analytical reasoning by cross-checking publication dates, journal impact factors, and peer review status before incorporating findings into responses.\n\n[SPEC 9] (ID: 07ba7022902c, Score: 70)\nSHOULD detect when medical analysis involves vulnerable populations including elderly patients or those with cognitive impairments and adjust reasoning complexity while emphasizing caregiver involvement needs.\n\n[SPEC 10] (ID: 5a9a6c18a8f4, Score: 85)\nMUST NOT proceed with symptom pattern analysis when user descriptions suggest active suicidal ideation, severe psychiatric crisis, or immediate physical danger without prioritizing emergency resource information.\n\n[SPEC 11] (ID: 2517dbb6a262, Score: 85)\nMUST detect when users request analysis of medical imaging, laboratory results, or diagnostic reports and redirect to qualified radiologist, pathologist, or clinician interpretation rather than providing automated analysis.\n\n[SPEC 12] (ID: 04eeebaab0ef, Score: 84)\nMUST NOT generate medication dosage calculations or drug interaction analyses without explicitly stating calculation limitations and requiring pharmacist or physician verification for clinical application.\n\n[SPEC 13] (ID: 27fa4a792bfe, Score: 82)\nMUST verify medical claims against peer-reviewed sources published within the last five years before presenting diagnostic or treatment information.\n\n[SPEC 14] (ID: 7ce341ac4163, Score: 81)\nMUST automatically detect and mask personally identifiable information including patient names, medical record numbers, social security numbers, healthcare provider identifiers, and insurance details before generating any medical analysis response.\n\n[SPEC 15] (ID: 3e1f2f41aa22, Score: 80)\nMUST automatically recognize when symptom analysis patterns suggest psychiatric emergencies, substance abuse crises, or self-harm indicators and prioritize crisis intervention resources over detailed analytical content.\n\n[SPEC 16] (ID: 5d29347aac9c, Score: 80)\nMUST verify that statistical claims and epidemiological reasoning include confidence intervals, study limitations, and population-specific applicability before presenting conclusions.\n\n[SPEC 17] (ID: 089297c4b07e, Score: N/A)\nMUST automatically detect and mask personally identifiable information including patient names, medical record numbers, social security numbers, and insurance identifiers when analyzing healthcare data or case studies.\n\n================================================================================\n\n**Output Format:**\nCOHESION_SCORE=<0-30>\nComment: [Brief explanation]\n\nCOVERAGE_SCORE=<0-25>\nComment: [Brief explanation]\n\nREDUNDANCY_SCORE=<0-25>\nComment: [Brief explanation]\n\nPRACTICALITY_SCORE=<0-20>\nComment: [Brief explanation]\n\nTOTAL=<sum>",
    "raw_response": "I'll evaluate this healthcare/medical analysis policy group according to the criteria:\n\nCOHESION_SCORE=28\nComment: The specs form a highly coherent framework with clear logical connections. They consistently emphasize professional medical oversight, uncertainty quantification, and safety-first approaches. The policies build on each other well - from general analytical constraints to specific scenario handling (emergencies, vulnerable populations, etc.). The group maintains a consistent focus on verification, safety, and appropriate deferrals to medical professionals.\n\nCOVERAGE_SCORE=24\nComment: Excellent comprehensive coverage across multiple dimensions: clinical analysis, medication management, mental health, emergency scenarios, vulnerable populations, data privacy, and source verification. The specs address both routine and crisis scenarios, covering primary risks (misdiagnosis, privacy breaches) and edge cases (rare diseases, psychiatric emergencies). The only minor gap might be in addressing emerging medical technologies/AI integration scenarios.\n\nREDUNDANCY_SCORE=20\nComment: While there is some overlap between specs (particularly 14 and 17 regarding PII masking, and some overlap in emergency response protocols), most redundancy appears intentional and appropriate for critical safety areas. The medication-related specs (5 and 12) have purposeful overlap for safety. Some consolidation opportunity exists but doesn't significantly impact effectiveness.\n\nPRACTICALITY_SCORE=18\nComment: The requirements are clearly actionable and include specific implementation guidance (e.g., 5-year recency requirement for sources, specific types of PII to mask). The balance between safety and functionality is well-maintained. However, some specs might require significant computational resources for full implementation (e.g., real-time drug interaction database verification, comprehensive source validation).\n\nTOTAL=90\n\nThe policy group demonstrates exceptional cohesion and coverage, with appropriate redundancy in critical areas and strong practicality. The high score reflects its comprehensive approach to medical analysis safety while maintaining implementability.",
    "parsed_scores": {
      "cohesion": 28,
      "coverage": 24,
      "redundancy": 20,
      "practicality": 18
    },
    "comments": {
      "cohesion": "The specs form a highly coherent framework with clear logical connections. They consistently emphasize professional medical oversight, uncertainty quantification, and safety-first approaches. The policies build on each other well - from general analytical constraints to specific scenario handling (emergencies, vulnerable populations, etc.). The group maintains a consistent focus on verification, safety, and appropriate deferrals to medical professionals.",
      "coverage": "Excellent comprehensive coverage across multiple dimensions: clinical analysis, medication management, mental health, emergency scenarios, vulnerable populations, data privacy, and source verification. The specs address both routine and crisis scenarios, covering primary risks (misdiagnosis, privacy breaches) and edge cases (rare diseases, psychiatric emergencies). The only minor gap might be in addressing emerging medical technologies/AI integration scenarios.",
      "redundancy": "While there is some overlap between specs (particularly 14 and 17 regarding PII masking, and some overlap in emergency response protocols), most redundancy appears intentional and appropriate for critical safety areas. The medication-related specs (5 and 12) have purposeful overlap for safety. Some consolidation opportunity exists but doesn't significantly impact effectiveness.",
      "practicality": "The requirements are clearly actionable and include specific implementation guidance (e.g., 5-year recency requirement for sources, specific types of PII to mask). The balance between safety and functionality is well-maintained. However, some specs might require significant computational resources for full implementation (e.g., real-time drug interaction database verification, comprehensive source validation)."
    },
    "total_score": 90,
    "temperature": 0.1,
    "max_tokens": 800
  },
  "final_group_scores": {
    "cohesion": 28,
    "coverage": 24,
    "redundancy": 20,
    "practicality": 18
  },
  "total_group_score": 90
}